| Wonderfully Made Therapy Services, Inc. | |
|
13130 Canyon Lakes Dr, Oklahoma City, OK 73142-7405 | |
| (405) 550-3380 | |
| (405) 550-3380 |
| Full Name | Wonderfully Made Therapy Services, Inc. |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist |
| Location | 13130 Canyon Lakes Dr, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104369438 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT892 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Wonderfully Made Therapy Services, Inc. 13130 Canyon Lakes Dr, Oklahoma City, OK 73142-7405 Ph: (405) 550-3380 | Wonderfully Made Therapy Services, Inc. 13130 Canyon Lakes Dr, Oklahoma City, OK 73142-7405 Ph: (405) 550-3380 |
News Archive
Now that the Supreme Court has remanded Association for Molecular Pathology et al. v. Myriad Genetics, Inc., et al. (AMP v. Myriad) to the Court of Appeals for the Federal Circuit for further consideration, AMP is optimistic that it will ultimately prevail in its lawsuit to invalidate patents on two genes that are known to cause breast cancer.
The [Tacoma, Wash.] News-Tribune reports that "elected officials worry that women face barriers to veterans benefits, especially health care. 'Once they get in, they see progress,' Sen. Patty Murray told The News Tribune in a phone interview last week. 'But the barriers they face now mean they don't always get the care they need.'
FibroGen, Inc., announced today that patient enrollment has started in a new Phase 2 clinical study of FG-3019 in patients who suffer from idiopathic pulmonary fibrosis.
Glythera Ltd is delighted to announce that it has successfully achieved a number of technical and commercial milestones which has resulted in the release of a second tranche of funding totalling £700k from IP Group and its managed fund, the Finance for Business North East Technology Fund.
Sanofi-aventis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion recommending to grant a marketing authorization in the European Union for Multaq(R) (dronedarone - 400mg Tablets).
› Verified 4 days ago
Jovan Pride, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5701 Se 74th St Ste G, Oklahoma City, OK 73135 Phone: 405-610-1909 Fax: 405-610-1910 | |
Tung Le, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3327 Nw 50th St, Oklahoma City, OK 73112 Phone: 405-946-7300 | |
Dr. Rachele Quinones, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6525 N Meridian Ave, Ste, Oklahoma City, OK 73116 Phone: 405-721-1115 | |
Keli A Boone, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1404 Nw 122nd St, Oklahoma City, OK 73114 Phone: 405-749-8131 | |
Caroline Jean Grubbs, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6400 N Santa Fe Ave, Suite B, Oklahoma City, OK 73116 Phone: 405-840-2903 Fax: 405-840-3256 | |
Ms. Denise Lashaun Shaw, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2828 Nw 57th St Ste 302, Oklahoma City, OK 73112 Phone: 405-840-1253 | |
Kallie Kim, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4220 Se 34th St, Oklahoma City, OK 73165 Phone: 785-213-1894 |